Interestingly, colorectal cancer patients achieved longer survival with EPHA7-WT instead of EPHA7-MUT (HR = 4.37 [95% CI 0.81–23.46], adjusted P = 0.08). This evidence concerns the gene EPHA7 and colorectal cancer.